Clinicopathological significance of the immunologic signature (PDL1, FOXP3+ Tregs, TILs) in early stage triple-negative breast cancer treated with neoadjuvant chemotherapy
Aziza E. Abdelrahman, Hayam E. Rashed, MostafaToam, Ayman Omar, Mohamed I. Abdelhamid, Ihab Matar
Topics & Concepts
FOXP3MedicineBreast cancerChemotherapyOncologyTumor-infiltrating lymphocytesStage (stratigraphy)Triple-negative breast cancerImmune systemImmunohistochemistryPathologicalNeoadjuvant therapyInternal medicineConcomitantCancerImmunotherapyImmunologyBiologyPaleontologyCancer Immunotherapy and BiomarkersCancer Cells and MetastasisImmunotherapy and Immune Responses